drugset / Trial / NCT01377532

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

NCT01377532 ↗

Expanded access Approved for marketing University of California, San Francisco

Summary

This is a compassionate use protocol to allow palliative therapy for patients with malignant pheochromocytoma and paragangliomas.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject 131 I-Metaiodobenzylguanidine (131 I-MIBG) Unknown 8 unknown Intravenous
Subject 131 I-Metaiodobenzylguanidine (131 I-MIBG) Unknown 12 unknown Intravenous